Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Not applicable Interventional

A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

ClinicalTrials.gov ID: NCT05400798

Public ClinicalTrials.gov record NCT05400798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a longitudinal follow-up study of the RC-002 study, in which up to 246 subjects assigned to two randomization arms will be enrolled: an adipose-derived regenerative cell (ADRC) injection arm (ADRC treatment arm) and the SOC corticosteroid injection arm (active control arm). All subjects will be randomly assigned to ADRC treatment or active control arms in a 2:1 ratio and will be followed up for 6 months. The goal of the RC-004 study is to enroll all patients that were enrolled and treated in RC-002 and follow for 3 years.

Study identification

NCT ID
NCT05400798
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Not applicable
Lead sponsor
InGeneron, Inc.
Industry
Enrollment
246 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 1, 2022 (Actual)
Primary completion
Sep 30, 2025 (Estimated)
Completion
Dec 30, 2025 (Estimated)
Last update posted
Aug 17, 2025

2022 – 2025

United States locations

U.S. sites
11
U.S. states
7
U.S. cities
11
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85053 —
Biosolutions Clinical Research Center La Mesa California 91942 —
Lotus Clinical Research, LLC Pasadena California 91105 —
Sports and Orthopedic Center Coral Springs Florida 33067 —
Universal Axon Clinical Research Doral Florida 33166 —
Andrews Institute for Orthopedics and Sports Medicine Gulf Breeze Florida 32561 —
Georgia Institute for Clinical Research Marietta Georgia 30060 —
Tulane University School of Medicine New Orleans Louisiana 70112 —
Sanford Orthopedic Clinic/Research Sioux Falls South Dakota 57104 —
HD Research Houston Texas 77041 —
Texas Center for Cell Therapy and Research San Antonio Texas 78240 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05400798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2025 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05400798 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →